Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol

Clinical trial NCT05334784 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05334784
Sponsor: Abiomed Inc.
Status: ENROLLING_BY_INVITATION
Phase: Not Applicable
Study type: INTERVENTIONAL

High-Risk Percutaneous Coronary Intervention

Start date: 2022-12-20
Primary completion: 2026-12-31
Enrollment: 856

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.